|
ATLANTA, GA (MARKET WIRE) 11/12/09
Market Pulse News Alert for this AM, Stocks to
Watch are: Arrayit Corporation (OTCBB: ARYC), Applied Materials
Inc. (NASDAQ: AMAT), 3Com Corporation (NASDAQ: COMS) and Medizone
International Inc. (OTCBB: MZEI).
Investors need to be watching Arrayit Corporation (OTCBB: ARYC) this AM!
Arrayit Corporation is engaged in the development, manufacture, and
marketing of life science technologies and integrated systems for the
analysis of genetic variation, biological function, and diagnostics.
Arrayit offers a product line of approximately 650 tools to 2,500
laboratories worldwide. The company's products include microarrayers,
microarray scanners, DNA and protein microarrays, microarray printing,
microarray substrates and slides, microarray instruments, amplification and
labeling, purification kits, microarray hardware, buffers and solutions,
microarray cleanrooms, books and software, CGH microarrays, and microarray
platforms. Arrayit's worldwide business position leverages the company's
widely used patented microarray manufacturing platform and revolutionary
VIP(TM) genotyping technology. Nearly every major research center in the
world uses Arrayit products including research laboratories, pharmaceutical
companies, universities, biotechnology companies, hospitals, government
agencies, and nonprofit research organizations. The company is also
involved in the import, export, and distribution of industrial and food
grade chemicals for plastics, fertilizers, and green energy applications.
It has research collaboration with The Parkinson's Institute of Sunnyvale
to discover biomarkers for Parkinson's disease. ARYC recently announced
that it is developing a microarray-based diagnostic test to detect the H1N1
swine flu virus. The 2009 swine flu outbreak has raised concerns at the CDC
and the World Health Organization (WHO). The CDC and WHO believe that the
current outbreak poses a pandemic risk because the H1N1 flu virus contains
genetic elements from both the swine and human influenza viruses, allowing
direct human-to-human transmission without the need for agricultural
contact. Arrayit is an exciting and innovative public company that strives
to increase shareholder equity by inventing, developing, manufacturing and
supplying sophisticated life sciences products and services to an extensive
customer base spanning 50 countries. Arrayit is a leader in the field of
molecular diagnostics with patented technology that allows the screening
and monitoring of up to 80,000 patient samples on a single microscope
slide, rather than testing one patient per slide as is currently practiced.
Their corporate philosophy is embodied by a highly skilled,
multidisciplinary team of investors, business professionals, scientists,
engineers and executive and support staff who place shareholder value,
product quality, customer service and price competitiveness as their
highest priorities. Arrayit empowers decisive strategic advantage and large
return on investment for their customers in the research, pharmaceutical,
diagnostic, and health care markets! ARYC has had several excellent press
releases out lately and one again before today's opening bell announcing
that the company is currently developing several diagnostic tests that will
provide early detection for cancers, neurodegenerative diseases and other
disease states! This could be great news for investors!
Arrayit Corporation (OTCBB: ARYC) announced today that the company's
majority owned subsidiary, Arrayit Diagnostics, Inc., will launch the most
intensive marketing campaign in the company's thirteen-year history. The
company is currently developing several diagnostic tests that will provide
early detection for cancers, neurodegenerative diseases and other disease
states. By conclusively identifying the genomic and proteomic biomarkers
for specific diseases, these tests will enable early stage diagnosis,
leading to life saving and cost saving treatments. Arrayit Diagnostics
will promote the commercialization of these tests from its international
headquarters in Houston, Texas.
Arrayit Diagnostics has named John Howell as its CEO and President.
"Arrayit Diagnostics has the potential to globally renovate the health care
sector, allowing the diagnostics community to rethink the way diseases are
diagnosed and treated. Rather than reacting after symptoms have already
appeared, our tests will allow early detection, enabling earlier
intervention and treatment for patients, reducing costs compared to later
stage treatments, and potentially saving lives," stated John Howell, who
brings his extensive experience serving as a senior executive of public
corporations to the company.
"We are very pleased to launch Arrayit Diagnostics. It is an endeavor we
have been striving to achieve for some time. Arrayit Diagnostics will
utilize the strong foundation built by Arrayit Corporation, and we have the
utmost confidence in Mr. Howell to see that Arrayit Diagnostics succeeds,"
stated Rene Schena, CEO of Arrayit Corp.
Utilizing a talented sales team and its massive network of 41 international
life science and diagnostics distributors located in 38 countries, Arrayit
will use this opportunity to expand its worldwide customer base of 10,000
research labs to become a significant global diagnostics company.
About Arrayit Corporation
Arrayit Corporation, headquartered in Sunnyvale, California, leads and
empowers the genetic, research, pharmaceutical, and diagnostic communities
through the discovery, development and manufacture of proprietary life
science technologies and consumables for disease prevention, treatment and
cure. It now offers over 650 products to a customer base of more than
10,000 laboratories worldwide, including most every major university,
pharmaceutical and biotech company, major agricultural and chemical
company, government agency, national research foundation and many private
sector enterprises. Please visit www.arrayit.com for more information.
Stocks in the news and acting well as of late include: Applied Materials
Inc. (NASDAQ: AMAT), 3Com Corporation (NASDAQ: COMS) and Medizone
International Inc. (OTCBB: MZEI).
Information contained herein is the opinion of Market-Pulse.com ("MP") and
is intended to be used strictly for informational purposes. You should be
aware that MP attempts to assure itself of the accuracy of the information
contained in the analyses it publishes. In this regard, MP does, at times,
rely on the accuracy of information supplied to it by the companies which
are the subject of MP's analyses and/or parties related to those companies.
MP also relies on the accuracy and integrity of information that is
contained in company press releases and reports filed with the SEC. The
companies mentioned in this publication have not approved the content or
timing of the information being published unless otherwise noted.
MP, because it relies on information supplied by various third parties
disclaims any responsibility for the accuracy of such information. Any
investor considering making an investment in any security which has been
the subject of a MP analysis or opinion should, before making any such
investment, consult with his/her market professional and/or do his/her own
independent research regarding the company which is the subject of an MP
opinion, recommendation or analysis.
Information regarding companies which MP has opined upon is normally
available from many sources including the subject company's filings with
the SEC and various press releases issued by the company.
You should be aware that MP is often compensated for issuing analyses,
recommendations or opinions concerning particular companies. Its opinion is
therefore not unbiased and you should consider this factor when evaluating
MP's statements regarding a company. MP has been compensated, in connection
with its profile of Arrayit Corporation, one hundred thousand shares of
Arrayit Corporation's common stock by a third party shareholder.
Additionally, MP bought for its own account in the open market, forty
thousand shares of Arrayit Corporation's shares for a total purchase price
of twenty three thousand eight hundred twenty dollars. To date, MP has sold
forty thousand shares of stock in Arrayit Corporation for proceeds totaling
twenty six thousand one hundred seventeen dollars. MP's officers and
directors reserve the right to buy additional shares of the companies
discussed in this opinion and may profit in the event those shares rise in
value. When MP receives shares as compensation for a profiled company, MP
may sell part or all of any such shares during the period in which MP is
performing such services. Market-Pulse.com and Market Pulse Breaking News
Alert are owned by Market Pulse LLC.
Contact:
Market Pulse
800.290.8935
Email Contact
|
